Neurocrine Biosciences, Inc.
NBIX
$108.31
$1.311.22%
NBIX
Valuation
NBIX
Low
2-Year Historical Range
NBIX
Average
High
Market Cap
10.67B
8.74B
15.52B
Enterprise Value
10.09B
8.12B
14.72B
Price/Earnings (TTM)
32.51
< 30.00
> 130.00
Earnings Per Share Growth (TTM)
35.69%
< 30.00%
> 640.00%
Price/Earnings To Growth (TTM)
0.91
0.04
1.03
Price/Sales (TTM)
4.67
0.39
8.10
Price/Book (Q)
4.11
4.11
> 20.00
Enterprise Value/Revenue (TTM)
4.28
< 0.000
7.413
Enterprise Value/EBITDA (TTM)
16.92
< 10.00
35.95
Enterprise Value/EBIT (TTM)
17.73
< 10.00
38.54
Dividends and Shares
NBIX
Low
2-Year Historical Range
NBIX
Average
High
Shares Outstanding
102.90M
97.10M
104.30M
Dividend Per Share (Most Recent)
--
--
--
Dividend Per Share (TTM)
--
--
--
Dividend Yield (TTM)
--
--
--
Payout Ratio (TTM)
--
--
--
Price History
NBIX
Low
2-Year Historical Range
NBIX
Average
High
Beta
0.80
0.20
0.80
1-Month Total Return
-6.53%
< -10.00%
> 10.00%
3-Month Total Return
-22.39%
-24.13%
> 10.00%
6-Month Total Return
-6.10%
< -10.00%
> 10.00%
Year to Date Total Return
-22.39%
-25.44%
> 0.00%
1-Year Total Return
-22.32%
-23.42%
> 30.00%
2-Year Total Return
6.09%
< 0.00%
> 60.00%
3-Year Total Return
9.74%
< 0.00%
> 60.00%
5-Year Total Return
23.97%
< 10.00%
> 70.00%
Profitability
NBIX
Low
2-Year Historical Range
NBIX
Average
High
Operating Margin (TTM)
24.15%
17.24%
26.23%
Profit Margin (TTM)
14.49%
4.00%
18.65%
Management Effectiveness
NBIX
Low
2-Year Historical Range
NBIX
Average
High
Return on Assets (TTM)
10.20%
7.65%
11.52%
Return on Equity (TTM)
14.16%
4.16%
18.16%
Income Statement
NBIX
Low
2-Year Historical Range
NBIX
Average
High
Revenue (TTM)
2.36B
1.60B
2.36B
Total Revenue (TTM)
2.36B
1.60B
2.36B
Total Revenue Growth (Q YOY)
21.84%
21.84%
30.37%
Revenue Per Share (TTM)
22.89
< 20.00
> 110.00
Gross Profit (TTM)
1.59B
1.07B
1.59B
EBITDA (TTM)
596.10M
292.90M
614.00M
EBIT (TTM)
569.00M
275.60M
588.30M
Net Income (TTM)
341.30M
< 130.00M
385.90M
Net Income Avl. to Common (TTM)
341.30M
< 130.00M
385.90M
Earnings Growth (Q YOY)
-30.20%
-31.94%
> 90.00%
EPS Diluted (TTM)
3.29
0.60
3.74
EPS Diluted Growth (Q YOY)
-30.74%
-33.68%
> 90.00%
Balance Sheet
NBIX
Low
2-Year Historical Range
NBIX
Average
High
Cash and Short-Term Inv. (Q)
1.08B
894.60M
1.23B
Cash Per Share (Q)
10.46
9.21
11.77
Total Current Assets (Q)
1.72B
1.43B
1.88B
Total Assets (Q)
3.72B
2.36B
3.72B
Total Current Liabilities (Q)
507.70M
374.10M
712.90M
Total Debt (Q)
495.70M
273.60M
495.70M
Total Liabilities (Q)
1.13B
675.30M
1.13B
Total Common Equity (Q)
2.59B
1.68B
2.72B
Total Preferred Equity (Q)
--
--
--
Total Equity (Q)
2.59B
1.68B
2.72B
Current Ratio (Q)
3.397
2.386
4.367
Book Value Per Share (Q)
26.05
17.28
26.87
Cash Flow
NBIX
Low
2-Year Historical Range
NBIX
Average
High
Cash from Operations (TTM)
595.40M
254.70M
645.40M
Cash from Investing (TTM)
-126.80M
-480.00M
-126.80M
Cash from Financing (TTM)
-486.70M
-486.70M
> -40.00M
Net Change in Cash (TTM)
-18.10M
< -20.00M
> 60.00M
Levered Free Cash Flow (TTM)
395.94M
187.85M
636.51M
TTM - Trailing twelve months. Q - Most recent quarter. YOY - Year over year.
